Oct 12, 2017 8:00am EDT Pieris Pharmaceuticals Appoints Ingmar Bruns, M.D., Ph.D., as Vice President of Clinical Development
Oct 02, 2017 8:00am EDT Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Trial for Fully Proprietary Lead IO Program, PRS-343
Sep 26, 2017 8:00am EDT Pieris Pharmaceuticals to Present at the LEERINK Partners Roundtable Series on Thursday, September 28 at 9:30 AM ET
Aug 10, 2017 8:00am EDT Pieris Pharmaceuticals Appoints Allan Reine, M.D., as Chief Financial Officer
Aug 09, 2017 5:20pm EDT Pieris Pharmaceuticals Reports Financial Results for the Second Quarter Ended June 30, 2017 and Provides Corporate Update
Aug 01, 2017 7:30am EDT Pieris Pharmaceuticals to Host Second Quarter 2017 Investor Call and Corporate Update on August 10, 2017
Jul 05, 2017 4:30pm EDT Pieris Pharmaceuticals Announces Results from 2017 Annual Meeting of Stockholders and Provides Update on Therapeutic Programs
Jun 27, 2017 8:00am EDT Pieris Pharmaceuticals Added to the Russell 2000(R) and Russell 3000(R) Indexes
Jun 12, 2017 8:30am EDT Pieris Pharmaceuticals Announces Expiration of HSR Waiting Period for Collaboration with AstraZeneca
